HomeNDC LookupRxCUI directory › RxCUI 2700346

Acellular tissue engineered vessel-tyod 40 CM Drug Implant — RxCUI 2700346

RxNorm drug concept · Semantic clinical drug
RxCUI 2700346 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2700346
Official nameAcellular tissue engineered vessel-tyod 40 CM Drug Implant
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asacellular tissue engineered vessel-tyod Vascular Implant
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Acellular tissue engineered vessel-tyod 40 CM Dr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acellular tissue engineered vessel-tyod 40 CM Drug Implant RxCUI 2700346

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Acellular tissue engineered vessel 2700338
    • Acellular tissue engineered vessel-tyod 2700340
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Symvess 2700347
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acellular tissue engineered vessel Drug Implant 2700343
    • Acellular tissue engineered vessel-tyod Drug Implant 2700345
    • Acellular tissue engineered vessel Drug Implant Product 2700342
    • Acellular tissue engineered vessel-tyod Drug Implant Product 2700344
    • Acellular tissue engineered vessel Drug Implant [Symvess] 2700350
    • Acellular tissue engineered vessel-tyod Drug Implant [Symvess] 2700351
    • Symvess Drug Implant Product 2700349
    • Drug Implant 657710
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acellular tissue engineered vessel-tyod 40 CM SCDC · 2700341
  • Acellular tissue engineered vessel Drug Implant SCDF · 2700343
  • Acellular tissue engineered vessel-tyod Drug Implant SCDFP · 2700345
  • Acellular tissue engineered vessel Drug Implant Product SCDG · 2700342
  • Acellular tissue engineered vessel-tyod Drug Implant Product SCDGP · 2700344

Brand-Name Concepts

  • Acellular tissue engineered vessel-tyod 40 CM Drug Implant [Symvess] SBD · 2700352
  • Acellular tissue engineered vessel-tyod 40 CM [Symvess] SBDC · 2700348
  • Acellular tissue engineered vessel Drug Implant [Symvess] SBDF · 2700350
  • Acellular tissue engineered vessel-tyod Drug Implant [Symvess] SBDFP · 2700351
  • Symvess Drug Implant Product SBDG · 2700349
  • Symvess BN · 2700347

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2700346 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83564-0110-00 1 BOX in 1 BAG (83564-110-00) / 1 IMPLANT in 1 BOX (83564-1... Symvess Humacyte Global, Inc. 2024-12-19
Observed labelers: Humacyte Global, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.